Diagnosis Biomedicine to List on SZSE

date: 2018-7-10

Diagnosis Biomedicine (Stock Code: 002932) will land on SME board on July 10, 2018.

 

Diagnosis Biomedicine is publicly offering 16.6463 million shares, including 16.6463 million IPO shares offered at 20.45 yuan per share and raising funds of 340 million yuan, and 0 share transferred by the existing shareholders at 0 yuan. The post-public-offering share capital of Diagnosis Biomedicine is 66.5851 million in total. Wuhan Easy Diagnosis Biomedicine Co., Ltd. principally engages in independent research and development, production and sale of POCT rapid diagnostic reagents and rapid detection equipment. In 2017, its operating income reached 165 million yuan with the net profit of 65.4926 million yuan.